Previous studies found that BAFF overexpressed peripheral blood and local tissues in tumor, inflammatory, and autoimmune diseases, and soluble form of BAFF was demonstrated to be a promising biomarker in reflecting disease activity and predicting prognosis [14, 17, 21, 33]. This evidence concerns the gene TNFSF13B and autoimmune disease.